ZYNROSBI
Live / Allowed — First extension granted (statement of use) (as of 10 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 08 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99433003
- Mark type
- Word mark
- Filed
- 08 Oct 2025
- Published for opposition
- 02 Dec 2025
- Attorney of record
- Christopher M Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders
Owner
- Nuvalent, Inc., Wilmington, DE, US
- Nuvalent, Inc., Cambridge, MA, US
Prosecution history
- 03 Sept 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Sept 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Sept 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 31 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 31 Aug 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 31 Aug 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Jul 2026 — SOU EXTENSION 1 GRANTED
- 10 Jul 2026 — SOU EXTENSION 1 FILED
- 10 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 27 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Dec 2025 — PUBLISHED FOR OPPOSITION
- 26 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER